Pharmacologic therapy for New York Heart Association class IV heart failure
© 2011 Wiley Periodicals, Inc..
As the incidence of heart failure increases, the number of patients with advanced heart failure is anticipated to grow. Substantial progress in the treatment of heart failure has been achieved over the past few decades. Several classes of medications have been studied and found effective, including beta-blockers, angiotensin converting enzyme inhibitors or angiotensin receptor blockers, aldosterone antagonists, vasodilators, digoxin, and inotropes. The evidence base for the use of these medications in the treatment of patients with New York Heart Association (NYHA) class IV heart failure is reviewed.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2011 |
|---|---|
| Erschienen: |
2011 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
|---|---|
| Enthalten in: |
Congestive heart failure (Greenwich, Conn.) - 17(2011), 5 vom: 01. Sept., Seite 213-9 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Caccamo, Marco A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 21.02.2012 Date Revised 12.09.2011 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/j.1751-7133.2011.00235.x |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM211361062 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM211361062 | ||
| 003 | DE-627 | ||
| 005 | 20231224013353.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2011 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/j.1751-7133.2011.00235.x |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0704.xml |
| 035 | |a (DE-627)NLM211361062 | ||
| 035 | |a (NLM)21906245 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Caccamo, Marco A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Pharmacologic therapy for New York Heart Association class IV heart failure |
| 264 | 1 | |c 2011 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 21.02.2012 | ||
| 500 | |a Date Revised 12.09.2011 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2011 Wiley Periodicals, Inc. | ||
| 520 | |a As the incidence of heart failure increases, the number of patients with advanced heart failure is anticipated to grow. Substantial progress in the treatment of heart failure has been achieved over the past few decades. Several classes of medications have been studied and found effective, including beta-blockers, angiotensin converting enzyme inhibitors or angiotensin receptor blockers, aldosterone antagonists, vasodilators, digoxin, and inotropes. The evidence base for the use of these medications in the treatment of patients with New York Heart Association (NYHA) class IV heart failure is reviewed | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 700 | 1 | |a Eckman, Peter M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Congestive heart failure (Greenwich, Conn.) |d 1998 |g 17(2011), 5 vom: 01. Sept., Seite 213-9 |w (DE-627)NLM096533935 |x 1751-7133 |7 nnns |
| 773 | 1 | 8 | |g volume:17 |g year:2011 |g number:5 |g day:01 |g month:09 |g pages:213-9 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/j.1751-7133.2011.00235.x |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 17 |j 2011 |e 5 |b 01 |c 09 |h 213-9 | ||